03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Prof. Roman Hovorka: no photograph is held, so the academic plate is shown instead.
Academic
Prof. Roman Hovorka
Founder of CamDiab
2
0
0
0
0
0
0
0
1
Mar 2026AprMayJuneJulyAugSeptOctNovto date
3
press citations on 1 topic since 10 Mar 2026 · last quoted 9 Nov 2026
02 Quoted on · 1 of 29 topics
Prof. Roman Hovorka: key facts
- Kind of voice
- Academic
- Role
- Founder of CamDiab
- Quoted on
- Diabetes
- Tracked press citations
- 3
- Most recently quoted
- 9 Nov 2026
- First quoted
- 10 Mar 2026
04 The signal · where Prof. Roman Hovorka sits on diabetes
Ranked 48= of 100 voices quoted in the press on diabetes, level with 35 others on 3 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 48=Anna ClarkeClinicianclinical research nurse3
- 48=Mark VerdantSector leaderclinical trials support officer at Somerset NHS Foundation Trust3
- 48=Prof. Roman HovorkaAcademicFounder of CamDiab3
- 48=Suzanne JacksonClinicianPaediatric diabetes specialist nurse, University Hospitals of Morecambe Bay NHS Foundation Trust3
- 48=Juan Carlos Bazo-AlvarezClinicianDr, from the department of epidemiology and health at University College London (UCL), one of the researchers on the study3
Showing the leaders and the ranks around 48=, of 100 voices · See every voice on the topic →
05 On the record · press
What Prof. Roman Hovorka has said
By outlet · linked articles
- cambridgeindependent.co.uk1
- chathamdailynews.ca1
- diabetestimes.co.uk1
Where Prof. Roman Hovorka has been quoted
- 01Advancing type 1 diabetes care during pregnancy: a Canadian firstchathamdailynews.ca · 9 Nov 2026
- 02CamDiab's Liberty feature is a boon for diabetes suffererscambridgeindependent.co.uk · 16 Mar 2026
- 03CamAPS Liberty®: the dawn of fully closed-loop technologydiabetestimes.co.uk · 10 Mar 2026
Verbatim
“Pregnancy places exceptional demands on glucose management, and this approval gives women in Canada access to adaptive technology at a time when tight control matters most.”
“CamAPS Liberty represents a huge milestone for the diabetes community, marking the dawn of commercially available fully closed-loop technology. Our focus has always been on people, not just innovation.”
“CamAPS Liberty represents a huge milestone for the diabetes community, marking the dawn of commercially available fully closed-loop technology. Our focus has always been on people, not just innovation.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.